Cargando…

The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study

Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which is the most optimal ratio in relation to respiratory morbidity. The aim was to investigate to what extent differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Torén, Kjell, Schiöler, Linus, Lindberg, Anne, Andersson, Anders, Behndig, Annelie F., Bergström, Göran, Blomberg, Anders, Caidahl, Kenneth, Engvall, Jan E., Eriksson, Maria J., Hamrefors, Viktor, Janson, Christer, Kylhammar, David, Lindberg, Eva, Lindén, Anders, Malinovschi, Andrei, Lennart Persson, Hans, Sandelin, Martin, Eriksson Ström, Jonas, Tanash, Hanan, Vikgren, Jenny, Johan Östgren, Carl, Wollmer, Per, Sköld, C. Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898324/
https://www.ncbi.nlm.nih.gov/pubmed/33284499
http://dx.doi.org/10.1111/cpf.12684
_version_ 1783653840077193216
author Torén, Kjell
Schiöler, Linus
Lindberg, Anne
Andersson, Anders
Behndig, Annelie F.
Bergström, Göran
Blomberg, Anders
Caidahl, Kenneth
Engvall, Jan E.
Eriksson, Maria J.
Hamrefors, Viktor
Janson, Christer
Kylhammar, David
Lindberg, Eva
Lindén, Anders
Malinovschi, Andrei
Lennart Persson, Hans
Sandelin, Martin
Eriksson Ström, Jonas
Tanash, Hanan
Vikgren, Jenny
Johan Östgren, Carl
Wollmer, Per
Sköld, C. Magnus
author_facet Torén, Kjell
Schiöler, Linus
Lindberg, Anne
Andersson, Anders
Behndig, Annelie F.
Bergström, Göran
Blomberg, Anders
Caidahl, Kenneth
Engvall, Jan E.
Eriksson, Maria J.
Hamrefors, Viktor
Janson, Christer
Kylhammar, David
Lindberg, Eva
Lindén, Anders
Malinovschi, Andrei
Lennart Persson, Hans
Sandelin, Martin
Eriksson Ström, Jonas
Tanash, Hanan
Vikgren, Jenny
Johan Östgren, Carl
Wollmer, Per
Sköld, C. Magnus
author_sort Torén, Kjell
collection PubMed
description Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which is the most optimal ratio in relation to respiratory morbidity. The aim was to investigate to what extent different ratios of FEV(1)/FVC were associated with any respiratory symptom. In a cross‐sectional general population study, 15,128 adults (50–64 years of age), 7,120 never‐smokers and 8,008 ever‐smokers completed a respiratory questionnaire and performed FEV(1) and FVC after bronchodilation. We calculated different ratios of FEV(1)/FVC from 0.40 to 1.0 using 0.70 as reference category. We analysed odds ratios (OR) between different ratios and any respiratory symptom using adjusted multivariable logistic regression. Among all subjects, regardless of smoking habits, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.82, OR 0.48 (95% CI 0.41–0.56). Among never‐smokers, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.81, OR 0.53 (95% CI 0.41–0.70). Among ever‐smokers, the odds for any respiratory symptom was lowest at FEV(1)/FVC = 0.81, OR 0.43 (95% CI 0.16–1.19), although the rate of inclining in odds was small in the upper part, that is FEV(1)/FVC = 0.85 showed similar odds, OR 0.45 (95% CI 0.38–0.55). We concluded that the odds for any respiratory symptoms continuously decreased with higher FEV(1)/FVC ratios and reached a minimum around 0.80–0.85, with similar results among never‐smokers. These results indicate that the optimal threshold associated with respiratory symptoms may be higher than 0.70 and this should be further investigated in prospective longitudinal studies.
format Online
Article
Text
id pubmed-7898324
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78983242021-03-03 The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study Torén, Kjell Schiöler, Linus Lindberg, Anne Andersson, Anders Behndig, Annelie F. Bergström, Göran Blomberg, Anders Caidahl, Kenneth Engvall, Jan E. Eriksson, Maria J. Hamrefors, Viktor Janson, Christer Kylhammar, David Lindberg, Eva Lindén, Anders Malinovschi, Andrei Lennart Persson, Hans Sandelin, Martin Eriksson Ström, Jonas Tanash, Hanan Vikgren, Jenny Johan Östgren, Carl Wollmer, Per Sköld, C. Magnus Clin Physiol Funct Imaging Original Articles Chronic airflow limitation (CAL) can be defined as fixed ratio of forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 after bronchodilation. It is unclear which is the most optimal ratio in relation to respiratory morbidity. The aim was to investigate to what extent different ratios of FEV(1)/FVC were associated with any respiratory symptom. In a cross‐sectional general population study, 15,128 adults (50–64 years of age), 7,120 never‐smokers and 8,008 ever‐smokers completed a respiratory questionnaire and performed FEV(1) and FVC after bronchodilation. We calculated different ratios of FEV(1)/FVC from 0.40 to 1.0 using 0.70 as reference category. We analysed odds ratios (OR) between different ratios and any respiratory symptom using adjusted multivariable logistic regression. Among all subjects, regardless of smoking habits, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.82, OR 0.48 (95% CI 0.41–0.56). Among never‐smokers, the lowest odds for any respiratory symptom was at FEV(1)/FVC = 0.81, OR 0.53 (95% CI 0.41–0.70). Among ever‐smokers, the odds for any respiratory symptom was lowest at FEV(1)/FVC = 0.81, OR 0.43 (95% CI 0.16–1.19), although the rate of inclining in odds was small in the upper part, that is FEV(1)/FVC = 0.85 showed similar odds, OR 0.45 (95% CI 0.38–0.55). We concluded that the odds for any respiratory symptoms continuously decreased with higher FEV(1)/FVC ratios and reached a minimum around 0.80–0.85, with similar results among never‐smokers. These results indicate that the optimal threshold associated with respiratory symptoms may be higher than 0.70 and this should be further investigated in prospective longitudinal studies. John Wiley and Sons Inc. 2020-12-22 2021-03 /pmc/articles/PMC7898324/ /pubmed/33284499 http://dx.doi.org/10.1111/cpf.12684 Text en © 2020 The Authors. Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Torén, Kjell
Schiöler, Linus
Lindberg, Anne
Andersson, Anders
Behndig, Annelie F.
Bergström, Göran
Blomberg, Anders
Caidahl, Kenneth
Engvall, Jan E.
Eriksson, Maria J.
Hamrefors, Viktor
Janson, Christer
Kylhammar, David
Lindberg, Eva
Lindén, Anders
Malinovschi, Andrei
Lennart Persson, Hans
Sandelin, Martin
Eriksson Ström, Jonas
Tanash, Hanan
Vikgren, Jenny
Johan Östgren, Carl
Wollmer, Per
Sköld, C. Magnus
The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
title The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
title_full The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
title_fullStr The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
title_full_unstemmed The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
title_short The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
title_sort ratio fev(1)/fvc and its association to respiratory symptoms—a swedish general population study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898324/
https://www.ncbi.nlm.nih.gov/pubmed/33284499
http://dx.doi.org/10.1111/cpf.12684
work_keys_str_mv AT torenkjell theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT schiolerlinus theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lindberganne theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT anderssonanders theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT behndigannelief theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT bergstromgoran theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT blomberganders theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT caidahlkenneth theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT engvalljane theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT erikssonmariaj theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT hamreforsviktor theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT jansonchrister theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT kylhammardavid theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lindbergeva theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lindenanders theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT malinovschiandrei theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lennartperssonhans theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT sandelinmartin theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT erikssonstromjonas theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT tanashhanan theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT vikgrenjenny theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT johanostgrencarl theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT wollmerper theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT skoldcmagnus theratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT torenkjell ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT schiolerlinus ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lindberganne ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT anderssonanders ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT behndigannelief ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT bergstromgoran ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT blomberganders ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT caidahlkenneth ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT engvalljane ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT erikssonmariaj ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT hamreforsviktor ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT jansonchrister ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT kylhammardavid ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lindbergeva ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lindenanders ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT malinovschiandrei ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT lennartperssonhans ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT sandelinmartin ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT erikssonstromjonas ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT tanashhanan ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT vikgrenjenny ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT johanostgrencarl ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT wollmerper ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy
AT skoldcmagnus ratiofev1fvcanditsassociationtorespiratorysymptomsaswedishgeneralpopulationstudy